DK0885229T3 - Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferon - Google Patents
Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferonInfo
- Publication number
- DK0885229T3 DK0885229T3 DK97914792T DK97914792T DK0885229T3 DK 0885229 T3 DK0885229 T3 DK 0885229T3 DK 97914792 T DK97914792 T DK 97914792T DK 97914792 T DK97914792 T DK 97914792T DK 0885229 T3 DK0885229 T3 DK 0885229T3
- Authority
- DK
- Denmark
- Prior art keywords
- ones
- carbazol
- potentiate
- gamma interferon
- interferon activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/604,474 US5616724A (en) | 1996-02-21 | 1996-02-21 | Fused pyrrolo[2,3-c]carbazole-6-ones |
| PCT/US1997/002905 WO1997031002A1 (en) | 1996-02-21 | 1997-02-20 | Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0885229T3 true DK0885229T3 (da) | 2000-10-16 |
Family
ID=24419747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97914792T DK0885229T3 (da) | 1996-02-21 | 1997-02-20 | Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferon |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5616724A (es) |
| EP (1) | EP0885229B1 (es) |
| JP (1) | JP2000505458A (es) |
| KR (1) | KR19990087074A (es) |
| CN (1) | CN1098266C (es) |
| AT (1) | ATE195124T1 (es) |
| AU (1) | AU716265B2 (es) |
| BR (1) | BR9707659A (es) |
| DE (1) | DE69702705T2 (es) |
| DK (1) | DK0885229T3 (es) |
| ES (1) | ES2150233T3 (es) |
| GR (1) | GR3034533T3 (es) |
| HK (1) | HK1017673A1 (es) |
| NZ (1) | NZ330837A (es) |
| PT (1) | PT885229E (es) |
| RU (1) | RU2193037C2 (es) |
| WO (1) | WO1997031002A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
| US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| NZ511024A (en) * | 1998-09-25 | 2003-10-31 | Cephalon Inc | Methods for preventing/treating damage to sensory hair cells, loss of hearing and cochlear neurons using fused pyrrolocarbazoles |
| US6656474B1 (en) * | 1999-01-15 | 2003-12-02 | Regeneron Pharmaceuticals, Inc. | Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| US6841567B1 (en) | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| US6399780B1 (en) * | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
| FR2798931B1 (fr) * | 1999-09-22 | 2001-11-16 | Oreal | Nouveaux composes indoliques, leur utilisation pour la teinture et le maquillage des matieres keratiniques, compositions les contenant et procedes de teinture |
| CA2405709A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US6630500B2 (en) | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
| AR035971A1 (es) * | 2001-05-16 | 2004-07-28 | Cephalon Inc | Metodos para el tratamiento y la prevencion del dolor |
| ES2545090T3 (es) | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina y GCSF |
| WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US20060134175A1 (en) * | 2004-12-22 | 2006-06-22 | Stephen Bartels | Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use |
| US20060134174A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
| US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
| WO2007002670A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Method of lowering intraocular pressure |
| WO2009067221A2 (en) * | 2007-11-20 | 2009-05-28 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| MX2011005055A (es) * | 2008-11-19 | 2011-05-31 | Cephalon Inc | Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol. |
| EP2192121A1 (en) | 2008-11-27 | 2010-06-02 | Cephalon France | Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552842A (en) * | 1983-01-28 | 1985-11-12 | Bristol-Myers Company | Process for producing rebeccamycin |
| EP0303697B1 (en) * | 1987-03-09 | 1997-10-01 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance k-252 |
| DE3835842A1 (de) * | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| CZ280738B6 (cs) * | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
| DE3833008A1 (de) * | 1988-09-29 | 1990-04-05 | Goedecke Ag | Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| MC2096A1 (fr) * | 1989-02-23 | 1991-02-15 | Hoffmann La Roche | Pyrroles substitues |
| CZ283049B6 (cs) * | 1989-12-20 | 1997-12-17 | Schering Corporation | Protein BCRF1 viru Epstein-Barr schopný inhibovat syntézu gama-interferonu, expresní vekter pro jeho syntézu a farmaceutický přípravek jej obsahující |
| DE3942296A1 (de) * | 1989-12-21 | 1991-06-27 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung |
| US5185260A (en) * | 1991-08-29 | 1993-02-09 | The United States Of America As Represented By The United States Department Of Energy | Method for distinguishing normal and transformed cells using G1 kinase inhibitors |
| NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
| US6271242B1 (en) * | 1992-02-10 | 2001-08-07 | Bristol-Myers Squibb Co. | Method for treating cancer using a tyrosine protein kinase inhibitor |
| US5405864A (en) * | 1993-10-15 | 1995-04-11 | Syntex (U.S.A.) Inc. | Chemotherapeutic maleimides |
-
1996
- 1996-02-21 US US08/604,474 patent/US5616724A/en not_active Expired - Lifetime
-
1997
- 1997-02-20 EP EP97914792A patent/EP0885229B1/en not_active Expired - Lifetime
- 1997-02-20 DE DE69702705T patent/DE69702705T2/de not_active Expired - Fee Related
- 1997-02-20 PT PT97914792T patent/PT885229E/pt unknown
- 1997-02-20 JP JP9530385A patent/JP2000505458A/ja not_active Ceased
- 1997-02-20 KR KR1019980706460A patent/KR19990087074A/ko active Search and Examination
- 1997-02-20 WO PCT/US1997/002905 patent/WO1997031002A1/en not_active Application Discontinuation
- 1997-02-20 AU AU21914/97A patent/AU716265B2/en not_active Ceased
- 1997-02-20 DK DK97914792T patent/DK0885229T3/da active
- 1997-02-20 RU RU98117389/04A patent/RU2193037C2/ru active
- 1997-02-20 BR BR9707659A patent/BR9707659A/pt not_active Application Discontinuation
- 1997-02-20 ES ES97914792T patent/ES2150233T3/es not_active Expired - Lifetime
- 1997-02-20 AT AT97914792T patent/ATE195124T1/de not_active IP Right Cessation
- 1997-02-20 NZ NZ330837A patent/NZ330837A/xx unknown
- 1997-02-20 CN CN97192377A patent/CN1098266C/zh not_active Expired - Fee Related
- 1997-03-28 US US08/827,215 patent/US5801190A/en not_active Expired - Fee Related
-
1999
- 1999-03-24 HK HK99101243A patent/HK1017673A1/xx not_active IP Right Cessation
-
2000
- 2000-10-02 GR GR20000402223T patent/GR3034533T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9707659A (pt) | 1999-04-13 |
| GR3034533T3 (en) | 2001-01-31 |
| JP2000505458A (ja) | 2000-05-09 |
| DE69702705D1 (de) | 2000-09-07 |
| EP0885229A1 (en) | 1998-12-23 |
| US5616724A (en) | 1997-04-01 |
| PT885229E (pt) | 2000-12-29 |
| ATE195124T1 (de) | 2000-08-15 |
| AU716265B2 (en) | 2000-02-24 |
| ES2150233T3 (es) | 2000-11-16 |
| WO1997031002A1 (en) | 1997-08-28 |
| DE69702705T2 (de) | 2001-04-05 |
| NZ330837A (en) | 1999-03-29 |
| AU2191497A (en) | 1997-09-10 |
| US5801190A (en) | 1998-09-01 |
| RU2193037C2 (ru) | 2002-11-20 |
| CN1211254A (zh) | 1999-03-17 |
| EP0885229B1 (en) | 2000-08-02 |
| HK1017673A1 (en) | 1999-11-26 |
| CN1098266C (zh) | 2003-01-08 |
| KR19990087074A (ko) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0885229T3 (da) | Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferon | |
| ID23374A (id) | Halogenopirimidin | |
| ES2110386T3 (es) | Conjugados de interferon. | |
| DE69404144D1 (de) | Bauschiger, stabiler vliesstoff | |
| FI910393A0 (fi) | Semi-termoplastisk matriskomposition med vaermestabilt formbestaendigt minne. | |
| BR9807848B1 (pt) | Composto de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos. | |
| MX9301751A (es) | Acidos amido peroxicarboxilicos. | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| MX9201681A (es) | 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas. | |
| FR2781481B1 (fr) | Nouveaux 2-amino, 4-alkylamino pyrimidine 3-oxydes et composition les comprenant | |
| YU12397A (en) | NOVEL PYRIMIDO [1,2-a] INDOLES | |
| MX9200431A (es) | Azapironas:el uso en el desorden de hiperactividad de la falta de atencion. | |
| FI945164A0 (fi) | Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina | |
| CA2241852A1 (en) | Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon | |
| ES1033492Y (es) | Mojon de limitacion vial, amovible. | |
| EA200400764A1 (ru) | 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение | |
| NO20021429D0 (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| SE9703905D0 (sv) | Upphängningsanordning | |
| ES1025295Y (es) | Esponja de un solo uso, perfeccionada. | |
| ES1032567Y (es) | Medias monopiezas hasta la cintura. | |
| ES1022892Y (es) | Pupitre armable de uso infantil. | |
| BR9612409A (pt) | 1,2,4,6-Tiatriazinas substituídas úteis como herbididas | |
| IT9032026V0 (it) | Calza, particolarmente per uso sportivo. | |
| DK129093D0 (da) | Stol, navnlig justerbar kontorstol | |
| IT220580Z2 (it) | Bicicletta, particolarmente per uso agonistico e sportivo. |